KOREAN
Company
Business
R & D
Investors
Company Overview
Welcome Message
Vision & Mission
History
C.I
Careers
Contact Us
Umbilical Cord Blood-derived Stem Cell
Stem Cell Therapy
Stem Cell Conditioned Media
Stem Cell Culture Media
Cell Freezing and Thawing Platform
CDMO
Health & Beauty(H&B) Business
Core Technology
Global R&D Center
Stem Cell GMP Center
Pipeline
Notice
IR
PR
Investors
Notice
IR
Disclosure Information
Stock Information
IR Resource Center
IR Letter & FAQ
PR
Press Release
PR Resource Center
IR Letter & FAQ
Investors
IR
IR Letter & FAQ
목록으로
[IR레터] 2022년 상반기 IR레터
2022.08.23
2022년 상반기 IR레터
목록으로
[IR FAQ] 2022년 상반기 NDR FAQ_임상, 재무 부문
[IR FAQ] 골관절염치료제 (FURESTEM-OA Kit주) 1/2a상임상시험계획(IND) 신청완료 및 향후 계획 관련 사항
About Us
Stock Information
Careers
Contact Us
Global R&D Center
Stem Cell GMP Center
Pipeline
TOP
board : irletter : view : : /board/irletter/view
